Data completeness
3/8 — Basic
NORLUTATE (norethindrone acetate) by Pfizer is clinical pharmacology norethindrone acetate induces secretory changes in an estrogen-primed endometrium. Approved for heavy menstrual bleeding, uterine fibroids, endometriosis and 5 more indications.
Drug data last refreshed 2w ago
Mechanism of Action
CLINICAL PHARMACOLOGY Norethindrone acetate induces secretory changes in an estrogen-primed endometrium. On a weight basis, it is twice as potent as norethindrone. Pharmacokinetics Absorption Norethindrone acetate is completely and rapidly deacetylated to norethindrone (NET) after oral…
Worked on NORLUTATE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.